Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study

Archive ouverte

Klompmaker, Sjors | van Hilst, Jony | Gerritsen, Sarah | Adham, Mustapha | Teresa Albiol Quer, M. | Bassi, Claudio | Berrevoet, Frederik | Boggi, Ugo | Busch, Olivier | Cesaretti, Manuela | Dalla Valle, Raffaele | Darnis, Benjamin | de Pastena, Matteo | del Chiaro, Marco | Grützmann, Robert | Diener, Markus | Dumitrascu, Traian | Friess, Helmut | Ivanecz, Arpad | Karayiannakis, Anastasios | Fusai, Giuseppe | Labori, Knut | Lombardo, Carlo | López-Ben, Santiago | Mabrut, Jean‐yves | Niesen, Willem | Pardo, Fernando | Perinel, Julie | Popescu, Irinel | Roeyen, Geert | Sauvanet, Alain | Prasad, Raj | Sturesson, Christian | Lesurtel, Mickaël | Kleeff, Jorg | Salvia, Roberto | Besselink, Marc

Edité par CCSD ; Springer Verlag -

International audience. Abstract Background Western multicenter studies on distal pancreatectomy with celiac axis resection (DP-CAR), also known as the Appleby procedure, for locally advanced pancreatic cancer are lacking. We aimed to study overall survival, morbidity, mortality and the impact of preoperative hepatic artery embolization (PHAE). Methods Retrospective cohort study within the European-African Hepato-Pancreato-Biliary-Association, on DP-CAR between 1-1-2000 and 6-1-2016. Primary endpoint was overall survival. Secondary endpoints were radicality (R0-resection), 90-day mortality, major morbidity, and pancreatic fistulae (grade B/C). Results We included 68 patients from 20 hospitals in 12 countries. Postoperatively, 53% of patients had R0-resection, 25% major morbidity, 21% an ISGPS grade B/C pancreatic fistula, and 16% mortality. In total, 82% received (neo-)adjuvant chemotherapy and median overall survival in 62 patients with pancreatic ductal adenocarcinoma patients was 18 months (CI 10–37). We observed no impact of PHAE on ischemic complications. Conclusions DP-CAR combined with chemotherapy for locally advanced pancreatic cancer is associated with acceptable overall survival. The 90-day mortality is too high and should be reduced. Future studies should investigate to what extent increasing surgical volume or better patient selection can improve outcomes.

Consulter en ligne

Suggestions

Du même auteur

Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): An International Multicenter Analysis

Archive ouverte | Klompmaker, Sjors | CCSD

International audience

Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment

Archive ouverte | van Roessel, Stijn | CCSD

International audience

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study

Archive ouverte | van Veldhuisen, Eran | CCSD

International audience. Abstract Background Preoperative FOLFIRINOX chemotherapy is increasingly administered to patients with borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC) to improve ov...

Chargement des enrichissements...